Rogers K - Search Results

1

A comparative immunological assessment of multiple clinical-stage adjuvants for the R21 malaria vaccine in nonhuman primates.

Arunachalam PS, Ha N, Dennison SM, Spreng RL, Seaton KE, Xiao P, Feng Y, Zarnitsyna VI, Kazmin D, Hu M, Santagata JM, Xie X, Rogers K, Shirreff LM, Chottin C, Spencer AJ, Dutta S, Prieto K, Julien JP, Tomai M, Fox CB, Villinger F, Hill AVS, Tomaras GD, Pulendran B. Arunachalam PS, et al. Among authors: rogers k. Sci Transl Med. 2024 Jul 31;16(758):eadn6605. doi: 10.1126/scitranslmed.adn6605. Epub 2024 Jul 31. Sci Transl Med. 2024. PMID: 39083589

2

Anti-CD3/28 mediated expansion of macaque CD4+ T cells is polyclonal and provides extended survival after adoptive transfer.

Onlamoon N, Plagman N, Rogers KA, Mayne AE, Bostik P, Pattanapanyasat K, Ansari AA, Villinger F. Onlamoon N, et al. Among authors: rogers ka. J Med Primatol. 2007 Aug;36(4-5):206-18. doi: 10.1111/j.1600-0684.2007.00238.x. J Med Primatol. 2007. PMID: 17669209

3

Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection.

Onlamoon N, Rogers K, Mayne AE, Pattanapanyasat K, Mori K, Villinger F, Ansari AA. Onlamoon N, et al. Among authors: rogers k. Immunology. 2008 Jun;124(2):277-93. doi: 10.1111/j.1365-2567.2007.02766.x. Epub 2008 Feb 5. Immunology. 2008. PMID: 18266718 Free PMC article.

4

Differences in the constitutive and SIV infection induced expression of Siglecs by hematopoietic cells from non-human primates.

Jaroenpool J, Rogers KA, Pattanapanyasat K, Villinger F, Onlamoon N, Crocker PR, Ansari AA. Jaroenpool J, et al. Among authors: rogers ka. Cell Immunol. 2007 Nov-Dec;250(1-2):91-104. doi: 10.1016/j.cellimm.2008.01.009. Epub 2008 Mar 10. Cell Immunol. 2007. PMID: 18331725 Free PMC article.

5

Infection, viral dissemination, and antibody responses of rhesus macaques exposed to the human gammaretrovirus XMRV.

Onlamoon N, Das Gupta J, Sharma P, Rogers K, Suppiah S, Rhea J, Molinaro RJ, Gaughan C, Dong B, Klein EA, Qiu X, Devare S, Schochetman G, Hackett J Jr, Silverman RH, Villinger F. Onlamoon N, et al. Among authors: rogers k. J Virol. 2011 May;85(9):4547-57. doi: 10.1128/JVI.02411-10. Epub 2011 Feb 16. J Virol. 2011. PMID: 21325416 Free PMC article.

6

Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication.

Pallikkuth S, Rogers K, Villinger F, Dosterii M, Vaccari M, Franchini G, Pahwa R, Pahwa S. Pallikkuth S, et al. Among authors: rogers k. Vaccine. 2011 Nov 15;29(49):9229-38. doi: 10.1016/j.vaccine.2011.09.118. Epub 2011 Oct 11. Vaccine. 2011. PMID: 21996099 Free PMC article.

7

Spatial alterations between CD4(+) T follicular helper, B, and CD8(+) T cells during simian immunodeficiency virus infection: T/B cell homeostasis, activation, and potential mechanism for viral escape.

Hong JJ, Amancha PK, Rogers K, Ansari AA, Villinger F. Hong JJ, et al. Among authors: rogers k. J Immunol. 2012 Apr 1;188(7):3247-56. doi: 10.4049/jimmunol.1103138. Epub 2012 Mar 2. J Immunol. 2012. PMID: 22387550 Free PMC article.

8

Treatment of SIV-infected sooty mangabeys with a type-I IFN agonist results in decreased virus replication without inducing hyperimmune activation.

Vanderford TH, Slichter C, Rogers KA, Lawson BO, Obaede R, Else J, Villinger F, Bosinger SE, Silvestri G. Vanderford TH, et al. Blood. 2012 Jun 14;119(24):5750-7. doi: 10.1182/blood-2012-02-411496. Epub 2012 May 1. Blood. 2012. PMID: 22550346 Free PMC article.

9

Re-evaluation of PD-1 expression by T cells as a marker for immune exhaustion during SIV infection.

Hong JJ, Amancha PK, Rogers K, Ansari AA, Villinger F. Hong JJ, et al. Among authors: rogers k. PLoS One. 2013;8(3):e60186. doi: 10.1371/journal.pone.0060186. Epub 2013 Mar 28. PLoS One. 2013. PMID: 23555918 Free PMC article.

10

In vivo blockade of the programmed cell death-1 pathway using soluble recombinant PD-1-Fc enhances CD4+ and CD8+ T cell responses but has limited clinical benefit.

Amancha PK, Hong JJ, Rogers K, Ansari AA, Villinger F. Amancha PK, et al. Among authors: rogers k. J Immunol. 2013 Dec 15;191(12):6060-70. doi: 10.4049/jimmunol.1302044. Epub 2013 Nov 13. J Immunol. 2013. PMID: 24227774 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,052 results

Search Page

Filters